Goldman Sachs Upgrades Charles River Labs (CRL) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Jefferies Reiterates Buy on Charles River Laboratories (CRL) After Meeting with Management
December 19, 2016 7:24 AM ESTJefferies reiterated a Buy rating and $93.00 price target on Charles River Laboratories (NYSE: CRL) after meeting with management. While not guiding 2017 yet, management believes macro industry growth trends are strong and unaffected by the election or funding. That leads to an organic... More
